U.S. market Closed. Opens in 6 hours

ARCT | Arcturus Therapeutics Holdings Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 17.53 - 18.30
52 Week Range 17.50 - 45.00
Beta 2.65
Implied Volatility 117.48%
IV Rank 94.22%
Day's Volume 217,496
Average Volume 358,704
Shares Outstanding 27,042,200
Market Cap 481,892,004
Sector Healthcare
Industry Biotechnology
IPO Date 2013-05-22
Valuation
Profitability
Growth
Health
P/E Ratio -6.62
Forward P/E Ratio N/A
EPS -2.69
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 180
Country USA
Website ARCT
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lung disease caused by mutations in cystic fibrosis transmembrane conductance regulator (CFTR) gene, as well as vaccine programs include LUNAR-COV19 and LUNAR-FLU. It has collaboration partnerships with Vinbiocare Biotechnology Joint Stock Company for the manufacture of COVID-19 vaccines; Janssen Pharmaceuticals, Inc. to develop nucleic acid-based therapeutic candidates for the treatment of hepatitis B virus; Ultragenyx Pharmaceutical, Inc. to develop mRNA therapeutic candidates for rare disease targets; CureVac AG to develop mRNA therapeutic and vaccine candidates for various indications; Singapore Economic Development Board and Duke-NUS Medical School to develop LUNAR-COV19 vaccine; and Millennium Pharmaceuticals, Inc. to discover siRNA medicines for the treatment of non-alcoholic steatohepatitis. The company was founded in 2013 and is headquartered in San Diego, California.
*Chart delayed
Analyzing fundamentals for ARCT we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see ARCT Fundamentals page.

Watching at ARCT technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on ARCT Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙